Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Lymphoma, Non-Hodgkin 3Prostatic Neoplasms 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Myelodysplastic Syndromes 2Lymphoma, B-Cell 2Lymphoma 2Leukemia, Hairy Cell 2Leukemia 2Hodgkin Disease 2Carcinoma in Situ 2Vulvar Neoplasms 1Vulvar Diseases 1Uterine Cervical Dysplasia 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Small Cell Lung Carcinoma 1Sarcoma, Alveolar Soft Part 1Philadelphia Chromosome 1Papillomavirus Infections 1Pain 1Neoplasm, Residual 1Neoplasm Metastasis 1Multiple Myeloma 1Mesothelioma 1Lymphoma, Mantle-Cell 1Lymphoma, Follicular 1Lymphoma, B-Cell, Marginal Zone 1Lung Neoplasms 1Leukemia, Myeloid, Acute 1Leukemia, Myelogenous, Chronic, BCR-ABL Positive 1

Interventions

Specimen Handling 9Magnetic Resonance Spectroscopy 9Cisplatin 6Biopsy 5Paclitaxel 4pembrolizumab 3Platinum 3Immunoglobulin G 3Disulfides 3Cetuximab 3Carboplatin 31,2-diaminocyclohexaneplatinum II citrate 3(225)Ac-DOTA-c(RGDyK) 3ipatasertib 2cemiplimab 2Taxes 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiosurgery 2Radiation 2Docetaxel 2Cytoreduction Surgical Procedures 2Bevacizumab 2ALT-803 2peposertib 1peginterferon alfa-2b 1interferon gamma-1b 1fludarabine phosphate 1fludarabine 1durvalumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Carcinoma × Acetaminophen × Clear all
NCT05035407 2025-12-02

T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers

National Institutes of Health Clinical Center (CC)

Phase 1 Terminated
36 enrolled 7 charts
Breast

Carcinoma, Neoplasm Metastasis, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡